Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jillian Kohler"'
Publikováno v:
Globalization and Health, Vol 19, Iss 1, Pp 1-11 (2023)
Abstract Background Health systems are often susceptible to corruption risks. Corruption within health systems has been found to negatively affect the efficacy, safety, and, significantly, equitable distribution of health products. Enforcing effectiv
Externí odkaz:
https://doaj.org/article/8ed72bd3b53e43bd9faae52a2859346e
Autor:
Quinn Grundy, Lisa Parker, Anna Wong, Terence Fusire, Deirdre Dimancesco, Klara Tisocki, Helena Walkowiak, Taryn Vian, Jillian Kohler
Publikováno v:
Globalization and Health, Vol 18, Iss 1, Pp 1-23 (2022)
Abstract Background Weak governance over public sector pharmaceutical policy and practice limits access to essential medicines, inflates pharmaceutical prices, and wastes scarce health system resources. Pharmaceutical systems are technically complex
Externí odkaz:
https://doaj.org/article/59312f7679a547b7903de04be65c2f75
Publikováno v:
BMJ Open, Vol 12, Iss 12 (2022)
Objectives Corruption undermines the quality of healthcare and leads to inequitable access to essential health products. WHO, Global Fund, United Nations Development Programme (UNDP) and World Bank are engaged in anti-corruption in health sectors glo
Externí odkaz:
https://doaj.org/article/0fe89871e45b4558af9cce29ea819ebe
Publikováno v:
BMJ Global Health, Vol 7, Iss 11 (2022)
Externí odkaz:
https://doaj.org/article/a7dea88e38d04d4ab156828e5e49ce37
Publikováno v:
Health and Human Rights, Vol 24, Iss 2, Pp 159-175 (2020)
Throughout the COVID-19 pandemic, international access to COVID-19 vaccines and other health technologies has remained highly asymmetric. This inequity has had a particularly deleterious impact on low- and middle-income countries, engaging concerns a
Externí odkaz:
https://doaj.org/article/9956abad1b754b6496926730b1e348d6
Autor:
Deborah Gleeson, Joel Lexchin, Ronald Labonté, Belinda Townsend, Marc-André Gagnon, Jillian Kohler, Lisa Forman, Kenneth C. Shadlen
Publikováno v:
Globalization and Health, Vol 15, Iss S1, Pp 1-17 (2019)
Abstract Background Trade and investment agreements negotiated after the World Trade Organization’s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) have included increasingly elevated protection of intellectual property r
Externí odkaz:
https://doaj.org/article/2c37946aa5c14aacacd5211ca6097a07
Autor:
Tamara Hafner, Marlon Banda, Jillian Kohler, Zaheer-Ud-Din Babar, Murray Lumpkin, Mojisola Christianah Adeyeye, Emmanuel Nfor, Francis Aboagye-Nyame, Javier Guzman
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 13, Iss 1 (2020)
The response to emergency public health challenges such as HIV, TB, and malaria has been successful in mobilising resources and scaling up treatment for communicable diseases. However, many of the remaining challenges in improving access to and appro
Externí odkaz:
https://doaj.org/article/6d57685bd66141b7836f813c23efc8db
Publikováno v:
Health and human rights. 24(2)
Throughout the COVID-19 pandemic, international access to COVID-19 vaccines and other health technologies has remained highly asymmetric. This inequity has had a particularly deleterious impact on low- and middle-income countries, engaging concerns a
Publikováno v:
BMJ open. 12(12)
ObjectivesCorruption undermines the quality of healthcare and leads to inequitable access to essential health products. WHO, Global Fund, United Nations Development Programme (UNDP) and World Bank are engaged in anti-corruption in health sectors glob
Autor:
Jillian Kohler
Publikováno v:
Journal of Pharmaceutical Health Services Research. 14:1-1